Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

381.02 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 381.02
Bid (Size) 381.35 (2)
Ask (Size) 382.97 (10)
Prev. Close 381.02
Today's Range 381.02 - 381.02
52wk Range 237.44 - 381.99
Shares Outstanding 45,091,184
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Risk Vs Reward Vs Folly: Navigating Investment Choices
During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of... 
Via Talk Markets
Is It Too Late to Buy Johnson & Johnson's Stock?
This healthcare juggernaut's recent quarterly results prove just how strong its business is. 
Via The Motley Fool

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+53.04%
+53.04%

More News

Read More
2 Best Buffett Stocks to Buy for the Long Haul
Via The Motley Fool
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
From Abiomed, Inc.
Via Business Wire
If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today
Via Benzinga
Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years
Via Benzinga
Will Investors Notice Exciting Sign On Abiomed's Chart?
Via Benzinga
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
Via The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
Via The Motley Fool
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
Via The Motley Fool
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
Via Benzinga
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Via MarketBeat
This Monster Dividend Stock Isn't Done Growing
Via The Motley Fool
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
Via Investor's Business Daily
First Patients in the World Treated with Impella RP Flex with SmartAssist
From Abiomed, Inc.
Via Business Wire
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Via The Motley Fool
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
Via Benzinga
Bear Market Blues? 3 of the Best Stocks to Own in 2023
Via The Motley Fool
Peering Into Abiomed's Recent Short Interest
Via Benzinga
ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
From Kahn Swick & Foti, LLC
Via Business Wire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Via MarketBeat
Topics Stocks
Exposures US Equities
2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
Via The Motley Fool
Better Buy: Johnson & Johnson vs. Abbott Laboratories
Via The Motley Fool
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.